Company
Crossbow Therapeutics
Expanding the reach of antibody therapeutics
Also known as Crossbow Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Cambridge, Massachusetts, United States
- Legal name
- Crossbow Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
a biotechnology company focused on developing a novel class of potent and precise antibody therapies to treat a broad range of cancers
Funding snapshot
- Total raised
- $157MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $77M2026-03-18
Funding rounds
- Series B
- $77M2026-03-18, Company stated
- Round, 2025
- $30.2M2025-09-17, SEC form D sold, 17 investors
- Series A
- $80M2023-07-11, Company stated
- Round, 2023
- $37.6M2023-03-29, SEC form D sold, 15 investors
Loading relationship preview